Affymetrix (Nasdaq: AFFX) reported earnings on July 31. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), Affymetrix beat slightly on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share grew. GAAP earnings per share dropped to a loss.

Gross margins grew, operating margins expanded, net margins dropped.

Revenue details
 Affymetrix logged revenue of $79.5 million. The 11 analysts polled by S&P Capital IQ hoped for sales of $78.5 million on the same basis. GAAP reported sales were 20% higher than the prior-year quarter's $66.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.

EPS details
 EPS came in at $0.04. The 13 earnings estimates compiled by S&P Capital IQ averaged $0.00 per share. Non-GAAP EPS were $0.04 for Q2 versus -$0.02 per share for the prior-year quarter. GAAP EPS were -$0.09 for Q2 compared to $0.43 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.

Margin details
 For the quarter, gross margin was 53.1%, 160 basis points better than the prior-year quarter. Operating margin was -4.2%, 470 basis points better than the prior-year quarter. Net margin was -7.7%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $78.6 million. On the bottom line, the average EPS estimate is $0.01.

Next year's average estimate for revenue is $318.7 million. The average EPS estimate is $0.02.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 341 members out of 405 rating the stock outperform, and 64 members rating it underperform. Among 102 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 89 give Affymetrix a green thumbs-up, and 13 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Affymetrix is hold, with an average price target of $4.67.

Looking for alternatives to Affymetrix? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.